Related Experiment Video
Updated: Jul 10, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells
Srirupa Roy1, Manjinder Kaur, Chapla Agarwal
1Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, 4200 East Ninth Street, Box C238, Denver, CO 80262, USA.
Abstract:
Recent studies have shown that silibinin induces p21/Cip1 and p27/Kip1 and G1 arrest in different prostate cancer cells irrespective of p53 status; however, biological significance and mechanism of such induction have not been studied. Here, using two different prostate cancer cell lines DU145 and 22Rv1, representing androgen-independent and androgen-dependent stages of malignancy, first we investigated the importance of p21 and p27 induction in silibinin-mediated G1 arrest. Silencing p21 and p27 individually by RNA interference showed marked reversal in G1 arrest; however, their simultaneous ablation showed additional reversal of G1 arrest in 22Rv1 but not DU145 cells. These results suggest that whereas relative importance of these molecules might be cell line specific, their induction by silibinin is essential for its G1 arrest effect. Next, studies were done to examine mechanisms of their induction where cycloheximide-chase experiments showed that silibinin increases p21 and p27 protein half-life. This effect was accompanied by strong reduction in Skp2 level and its binding with p21 and p27 together with strong decrease in phosphorylated Thr(187) p27 without considerable change in proteasomal activity, suggesting a posttranslational mechanism. Skp2 role was further elucidated using Skp2-small interfering RNA-transfected cells, where decreased G1 arrest and attenuated Cip/Kip induction were observed with silibinin treatment. Further, silibinin caused a marked increase in p21 and p27 mRNA levels together with an increase in their promoter activity, also indicating a transcriptional mechanism. Together, our results for the first time identify a central role of p21 and p27 induction and their regulatory mechanism in silibinin-mediated cell cycle arrest.
Insights
Silibinin halts prostate cancer cell growth by increasing p21 and p27 protein levels. This study reveals silibinin
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Silibinin is known to induce cell cycle arrest (G1 arrest) in prostate cancer cells.
- The precise mechanisms and biological significance of p21/Cip1 and p27/Kip1 induction by silibinin remain unclear.
- Prostate cancer cell lines DU145 (androgen-independent) and 22Rv1 (androgen-dependent) were used to investigate these effects.
Purpose of the Study:
- To investigate the role of p21 and p27 induction in silibinin-mediated G1 arrest in prostate cancer cells.
- To elucidate the underlying molecular mechanisms of p21 and p27 induction by silibinin.
- To determine the contribution of Skp2 in silibinin's effects on cell cycle regulation.
Main Methods:
- RNA interference was used to silence p21 and p27 expression.
- Cycloheximide-chase experiments assessed protein stability.
- Western blotting and quantitative PCR analyzed protein and mRNA levels, respectively.
- Promoter activity assays and small interfering RNA (siRNA) transfections were employed to study regulatory mechanisms.
Main Results:
- Silencing p21 and p27 individually partially reversed G1 arrest; simultaneous silencing showed additional reversal in 22Rv1 cells.
- Silibinin increased the protein half-life of p21 and p27 by reducing Skp2 levels and its binding to these proteins.
- Silibinin also increased p21 and p27 mRNA levels and promoter activity, indicating transcriptional regulation.
- Skp2 knockdown attenuated silibinin-induced G1 arrest and p21/p27 induction.
Conclusions:
- p21 and p27 induction are essential for silibinin-mediated G1 arrest in prostate cancer cells, with cell-specific variations in their relative importance.
- Silibinin employs both post-translational (via Skp2 regulation) and transcriptional mechanisms to increase p21 and p27 levels.
- These findings identify a critical role for p21 and p27 regulation in silibinin's anti-cancer effects on prostate cancer cells.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

